Andrew Grethlein was Promoted as Executive Vice President and Chief Operating Officer at Geron

Date of management change: January 31, 2019 

What Happened?

Menlo Park, CA-based Geron Promoted Andrew Grethlein as Executive Vice President and Chief Operating Officer


About the Company

We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.


About the Person

Andrew J. Grethlein is Executive Vice President and Chief Operating Officer at Geron. Previously, Andrew held various senior HR leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Brock L.J., Wickline Julie, White Mike, Llewellyn Lori, Lopes Eduardo, Scott Debbie, Clatur Scott, Owen Kandi, Carruthers Nathalie, Gottlieb Pamela, Yanez Lety

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.